Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis

Journal of Urology

Volumn 156, Issue 1, 1996, Pages 45-48

  Morales, Alvaro ^a,b   Emerson, Laurel ^a   Nickel, J Curtis ^a   Lundie, Mark ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

bladder diseases; cystitis; glycosaminoglycans; hyaluronic acid

Indexed keywords

GLYCOSAMINOGLYCAN; HYALURONIC ACID;

ADULT; ARTICLE; BASEMENT MEMBRANE; BLADDER EPITHELIUM; BLADDER MUCOSA; CELL SURFACE; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HUMAN; INTERSTITIAL CYSTITIS; INTRAVESICAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; UROTHELIUM;

EID: 0029934186     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65933-0     Document Type: Article

References (27)

1. Parsons, C. L., Lilly, J. D. and Stein, P.: Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J. Urol., 145: 732, 1991.
2. Ruggieri, M. R., Chelsky, M. J., Rosen, S. I., Schikley, T. J. and Hanno, P. M.: Current findings and future research avenues in the study of interstitial cystitis. Urol. Clin. N. Amer., 21: 163, 1994.
3. Nickel, J. C., Emerson, L. and Cornish, J.: The bladder mucus (glycosaminoglycan) layer in interstitial cystitis. J. Urol., 149: 716, 1993.
4. Anderström, C., Fall, M. and Johansson, S.: Scanning electron microscopic findings in interstitial cystitis. Brit. J. Urol., 63: 270, 1989.
5. Sant, G. R., Ucci, A. A., Jr. and Alroy, J.: Bladder surface glycosaminoglycans (GAGs) in interstitial cystitis. J. Urol., part 2, 135: 175A, abstract 287, 1986.
6. Ratliff, T. L., Klutke, C. G. and McDougall, E. M.: The etiology of interstitial cystitis. Urol. Clin. N. Amer., 21: 21, 1994.
7. Emtage, J., Morales, A., Heaton, J. P. W. and Perez-Marrero, R.: Heparin in the treatment of interstitial cystitis. J. Urol., part 2, 133: 168A, abstract 220, 1985.
8. Perez-Marrero, R., Emerson, L., Maharajh, D. and Juma, S.: Prolongation of response to DMSO by heparin maintenance. Urology, suppl., 41: 64, 1993.
9. Sant, G. R. and LaRock, D. R.: Standard intravesical therapies for interstitial cystitis. Urol. Clin. N. Amer., 21: 73, 1994.
10. Parsons, C. L.: The therapeutic role of sulfated polysaccharides in urinary bladder. Urol. Clin. N. Amer., 21: 93, 1994.
11. Pitsillides, A. A., Will, R. K., Bayliss, M. T. and Edwards, J. C.: Circulating and synovial fluid hyaluronan levels. Effects of intraarticular corticosteroid on the concentration and the rate of turnover. Arth. Rheum., 7: 1030, 1994.
12. Sharif, M., George, E., Shepstone, L., Knudson, W., Thonar, E. J., Cushnagan, J. and Dieppe, P.: Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arth. Rheum., 38: 760, 1995.
13. Houpt, J. B. and Aviad, A.: Osteoarthritis (OA) of the knee: effect of intra-articular (I.A.) sodium hyaluronate (HA). Clin. Exp. Rheumatol., 4: 80, abstract P180, 1990.
14. Hurst, R. E., Rhodes, S. W., Adamson, P. B., Parsons, C. L. and Roy, J. B.: Functional and structural characteristics of the glycosaminoglycans of the bladder luminal surface. J. Urol., 138: 433, 1987.
15. Gillenwater, J. Y. and Wein, A. J.: Summary of the National Institute of Arthritis, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J. Urol., 140: 203, 1988.
16. R (sodium hyaluronate) in the treatment of osteoarthritis of human knees. Sem. Arth. Rheum., suppl. 1, 11: 143, 1981.
17. Goldberg, R. L., Huff, J. P., Lenz, M. E., Glickman, P., Katz, R. and Thonar, E. J.: Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arth. Rheum., 34: 799, 1991.
18. Sato, H., Takahashi, T., Ide, H., Fukushima, T., Tabata, M., Sekine, F., Kobayashi, K., Negishi, M. and Niwa, Y.: Antioxidant activity of synovial fluid, hyaluronic acid and two subcomponents of hyaluronic acid. Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients. Arth. Rheum., 31: 63, 1988.
19. Balasz, E. A. and Denlinger, J. L.: The role of hyaluronic acid in arthritis and its therapeutic use. In: Osteoarthritis: Current Clinical and Fundamental Problems. Edited by J. G. Peyron. Basel: Geigy, pp. 165-174, 1984.
20. Goldberg, R. L. and Toole, B. P.: Hyaluronate inhibition of cell proliferation. Arth. Rheum., 30: 769, 1987.
21. Abatangelo, G., Martelli, M. and Vecchia, P.: Healing of hyaluronic acid-enriched wounds: histological observations. J. Surg. Res., 35: 410, 1983.
22. Hadler, N. M. and Napier, M. A.: Structure of hyaluronic acid in synovial fluid and its influence on the movement of solutes. Sem. Arth. Rheum., 7: 141, 1977.
23. Aviad, A. D. and Houpt, J. B.: The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it? J. Rheumatol., 21: 297, 1994.
24. Asheim, A. and Lindblad, G.: Intra-articular treatment of arthritis in race horses with sodium hyaluronate. Acta Vet. Scand., 17: 379, 1976.
25. Hanno, P. M. and Wein, A. J.: Medical treatment of interstitial cystitis (other than Rimso-50E/miron). Urology, suppl., 29: 22, 1987.
26. Holm-Bentzen, M., Jacobsen, F., Nerstrom, B., Rose, G., Kristensen, J. K., Pedersen, R. H., Krarup, T., Feggeter, J., Bates, P., Barnard, R., Larsen, S. and Hald, T.: A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J. Urol., 138: 503, 1987.
27. Fritjosson, A., Fall, M., Juhlin, R., Persson, B. E. and Ruutu, M.: Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multicenter trial. J. Urol., 138: 508, 1987.